XTL Biopharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 26,447,099 | 2.16% |
| Individual Insiders | 131,648,196 | 10.8% |
| General Public | 1,066,026,154 | 87.1% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 124.6%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 128,288,887 | US$3.0m | 0% | no data | |||
| 19,888,800 | US$470.6k | 0% | 0.05% | |||
| 3,315,100 | US$78.4k | -15.4% | no data | |||
| 3,019,309 | US$71.4k | 0% | no data | |||
| 1,543,500 | US$36.5k | 13.2% | no data | |||
| 883,900 | US$20.9k | 1.8% | no data | |||
| 558,400 | US$13.2k | 0% | no data | |||
| 340,000 | US$8.0k | 0% | no data | |||
| 252,606 | US$6.0k | -15.8% | no data | |||
| 4,793 | US$113.0 | -97.7% | no data |